EVERYTHINGHR FINANCIAL SERVICES LLC

Curtis Lee is the Managing Member and appears to exercise sole investment discretion. The firm's SEC filings list Lee as the control person, and no investment committee or external portfolio managers are publicly identified. The lean governance structure is consistent with a principal-led investment office where sourcing and capital allocation remain consolidated under one decision-maker.

The firm benefits from its affiliation with the EverythingHR operating company, which serves mid-market employers with HR compliance and workforce-management software. That commercial relationship base provides early visibility into staffing-intensive businesses experiencing growth or operational scaling. While the firm does not publicly describe its sourcing process, the structural overlap between software clients and investment targets constitutes an implicit origination channel.

The firm is organized as an exempt reporting adviser under SEC rules, which places it closer to an asset manager than a pure single family office. This regulatory posture suggests it may manage outside capital alongside proprietary wealth, though the firm does not publicly confirm whether it accepts third-party funds. The operational tie to the EverythingHR software business creates a hybrid structure that does not fit neat single-family-office classification.

Public records do not confirm any fund-of-funds activity or GP commitments. Available evidence points toward direct private-company investments, consistent with a concentrated portfolio approach rather than broad fund allocation. Without public AUM or portfolio disclosures, the balance between direct investments and external fund commitments remains unverifiable.

The firm does not publish an exclusion list. Sector focus appears gravitated toward enterprise-facing businesses where workforce operations are a material value driver, specifically enterprise software and financial services. Capital-intensive industries such as hard-tech manufacturing, energy extraction, and biotech appear absent from the investable universe described in public filings.